Insiders Make Big Moves in Enovis Corp and Other US Stocks
Several high-profile insider trading activities have been disclosed for US stocks in September. In one notable instance, Enovis Corp's CEO and Director Damien McDonald purchased 13,035 shares on September 4, 2026, at a cost of $249,620. The timing is significant as the stock currently trades near its 52-week low.
Enovis Corp also received confidence from Chief Administrative Officer Oliver Engert, who bought company stock totaling $149,970 on September 2, 2026. This comes as the stock trades at $18.56, just above its 52-week low of $18.52.
Atara Biotherapeutics director Brian N. Cherry purchased 104,166 shares of the company's common stock on September 4, 2026, for approximately $999,993. The purchase comes as the stock trades at $9.76, reflecting an 81% surge over the past six months.
Smith-Midland Corp saw insider buying from both its CEO and a director last week. Director Matthew I. Smith acquired shares of the company's common stock through an open-market transaction on September 2, 2026, totaling $54,300.